MedTrace Logo

Impact of a Pharmacovigilance Program Led by Advanced Practice Nursing

NCT05402254 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 395

Last updated 2024-10-18

No results posted yet for this study

Summary

HYPOTHESIS An advanced practice nursing intervention in the area of pharmacovigilance performed on patients and professionals improves the identification and reporting of suspected adverse drug reactions (ADR) and improves the overall experience of hospitalized patients.

Conditions

  • Adverse Drug Event

Interventions

OTHER

Pharmacovigilance Program

Knowledge of the risks in the use of the drug, identification and notification of ADE

Sponsors & Collaborators

  • Natalia Rodriguez Galan

    lead OTHER

Principal Investigators

  • Natalia Rodriguez Galán · Hospital San Carlos

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2022-11-01
Completion
2022-12-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05402254 on ClinicalTrials.gov